[
  {
    "ts": "2025-11-10T09:00:00+00:00",
    "headline": "AHF’s Mobile Billboard Calls Out Gilead’s Greed at Pharma Summit",
    "summary": "LOS ANGELES, November 10, 2025--As the pharmaceutical industry gathers for the Global Pharma & Biotech Summit in London this week, AIDS Healthcare Foundation (AHF) is launching a mobile billboard that will circle the venue (Convene 22 Bishopsgate) on Nov. 11-12 to spotlight Gilead Sciences’ greed and refusal to make its breakthrough HIV prevention drug lenacapavir truly affordable and accessible.",
    "url": "https://finance.yahoo.com/news/ahf-mobile-billboard-calls-gilead-090000362.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "c003653a-5927-3b72-9245-96d12ec10104",
      "content": {
        "id": "c003653a-5927-3b72-9245-96d12ec10104",
        "contentType": "STORY",
        "title": "AHF’s Mobile Billboard Calls Out Gilead’s Greed at Pharma Summit",
        "description": "",
        "summary": "LOS ANGELES, November 10, 2025--As the pharmaceutical industry gathers for the Global Pharma & Biotech Summit in London this week, AIDS Healthcare Foundation (AHF) is launching a mobile billboard that will circle the venue (Convene 22 Bishopsgate) on Nov. 11-12 to spotlight Gilead Sciences’ greed and refusal to make its breakthrough HIV prevention drug lenacapavir truly affordable and accessible.",
        "pubDate": "2025-11-10T09:00:00Z",
        "displayTime": "2025-11-10T09:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ahf-mobile-billboard-calls-gilead-090000362.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ahf-mobile-billboard-calls-gilead-090000362.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-10T12:00:00+00:00",
    "headline": "Compugen Reports Third Quarter 2025 Results",
    "summary": "Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today reported financial results for the third quarter of 2025 and provided a corporate update.",
    "url": "https://finance.yahoo.com/news/compugen-reports-third-quarter-2025-120000372.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "146fed51-6288-3d84-955d-87ab8aabb803",
      "content": {
        "id": "146fed51-6288-3d84-955d-87ab8aabb803",
        "contentType": "STORY",
        "title": "Compugen Reports Third Quarter 2025 Results",
        "description": "",
        "summary": "Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today reported financial results for the third quarter of 2025 and provided a corporate update.",
        "pubDate": "2025-11-10T12:00:00Z",
        "displayTime": "2025-11-10T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/bc2cfd9890e471d6afc8bb0bfbcc8114",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6TtDlDON_WRcBpT1tyciRw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/bc2cfd9890e471d6afc8bb0bfbcc8114.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LWgt6YvOoZDilUqhGa2LYA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/bc2cfd9890e471d6afc8bb0bfbcc8114.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/compugen-reports-third-quarter-2025-120000372.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/compugen-reports-third-quarter-2025-120000372.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CGEN"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "AZN.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]